These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 30327539)

  • 21. Integrating rare genetic variants into pharmacogenetic drug response predictions.
    Ingelman-Sundberg M; Mkrtchian S; Zhou Y; Lauschke VM
    Hum Genomics; 2018 May; 12(1):26. PubMed ID: 29793534
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recommendations for pharmacogenetic testing in clinical practice guidelines in the US.
    Hertz DL; Bousman CA; McLeod HL; Monte AA; Voora D; Orlando LA; Crutchley RD; Brown B; Teeple W; Rogers S; Patel JN
    Am J Health Syst Pharm; 2024 Aug; 81(16):672-683. PubMed ID: 38652504
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Advancing Pharmacogenomics from Single-Gene to Preemptive Testing.
    Haidar CE; Crews KR; Hoffman JM; Relling MV; Caudle KE
    Annu Rev Genomics Hum Genet; 2022 Aug; 23():449-473. PubMed ID: 35537468
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multi-site investigation of strategies for the clinical implementation of CYP2D6 genotyping to guide drug prescribing.
    Cavallari LH; Van Driest SL; Prows CA; Bishop JR; Limdi NA; Pratt VM; Ramsey LB; Smith DM; Tuteja S; Duong BQ; Hicks JK; Lee JC; Obeng AO; Beitelshees AL; Bell GC; Blake K; Crona DJ; Dressler L; Gregg RA; Hines LJ; Scott SA; Shelton RC; Weitzel KW; Johnson JA; Peterson JF; Empey PE; Skaar TC;
    Genet Med; 2019 Oct; 21(10):2255-2263. PubMed ID: 30894703
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical pharmacogenetics: how do we ensure a favorable future for patients?
    Wiltshire T; Dong OM
    Pharmacogenomics; 2018 Apr; 19(6):553-562. PubMed ID: 29620450
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence and resources to implement pharmacogenetic knowledge for precision medicine.
    Caudle KE; Gammal RS; Whirl-Carrillo M; Hoffman JM; Relling MV; Klein TE
    Am J Health Syst Pharm; 2016 Dec; 73(23):1977-1985. PubMed ID: 27864205
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Advancing precision medicine in healthcare: addressing implementation challenges to increase pharmacogenetic testing in the clinical setting.
    Dong OM; Wiltshire T
    Physiol Genomics; 2017 Jul; 49(7):346-354. PubMed ID: 28550089
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The challenges of implementing pharmacogenomic testing in the clinic.
    Moyer AM; Caraballo PJ
    Expert Rev Pharmacoecon Outcomes Res; 2017 Dec; 17(6):567-577. PubMed ID: 28949250
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mapping the Pharmacogenetic Landscape in a Ugandan Population: Implications for Personalized Medicine in an Underrepresented Population.
    Samarasinghe SR; Lee SB; Corpas M; Fatumo S; Guchelaar HJ; Nagaraj SH
    Clin Pharmacol Ther; 2024 Oct; 116(4):980-995. PubMed ID: 38837390
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preemptive Pharmacogenomic Testing for Precision Medicine: A Comprehensive Analysis of Five Actionable Pharmacogenomic Genes Using Next-Generation DNA Sequencing and a Customized CYP2D6 Genotyping Cascade.
    Ji Y; Skierka JM; Blommel JH; Moore BE; VanCuyk DL; Bruflat JK; Peterson LM; Veldhuizen TL; Fadra N; Peterson SE; Lagerstedt SA; Train LJ; Baudhuin LM; Klee EW; Ferber MJ; Bielinski SJ; Caraballo PJ; Weinshilboum RM; Black JL
    J Mol Diagn; 2016 May; 18(3):438-445. PubMed ID: 26947514
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical implementation of pharmacogenomics via a health system-wide research biobank: the University of Colorado experience.
    Aquilante CL; Kao DP; Trinkley KE; Lin CT; Crooks KR; Hearst EC; Hess SJ; Kudron EL; Lee YM; Liko I; Lowery J; Mathias RA; Monte AA; Rafaels N; Rioth MJ; Roberts ER; Taylor MR; Williamson C; Barnes KC
    Pharmacogenomics; 2020 Apr; 21(6):375-386. PubMed ID: 32077359
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Concordance between Research Sequencing and Clinical Pharmacogenetic Genotyping in the eMERGE-PGx Study.
    Rasmussen-Torvik LJ; Almoguera B; Doheny KF; Freimuth RR; Gordon AS; Hakonarson H; Hawkins JB; Husami A; Ivacic LC; Kullo IJ; Linderman MD; Manolio TA; Obeng AO; Pellegrino R; Prows CA; Ritchie MD; Smith ME; Stallings SC; Wolf WA; Zhang K; Scott SA
    J Mol Diagn; 2017 Jul; 19(4):561-566. PubMed ID: 28502727
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Computational Tools to Assess the Functional Consequences of Rare and Noncoding Pharmacogenetic Variability.
    Zhou Y; Lauschke VM
    Clin Pharmacol Ther; 2021 Sep; 110(3):626-636. PubMed ID: 33998671
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of the PGx-Passport: A Panel of Actionable Germline Genetic Variants for Pre-Emptive Pharmacogenetic Testing.
    van der Wouden CH; van Rhenen MH; Jama WOM; Ingelman-Sundberg M; Lauschke VM; Konta L; Schwab M; Swen JJ; Guchelaar HJ
    Clin Pharmacol Ther; 2019 Oct; 106(4):866-873. PubMed ID: 31038729
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predicted efficacy of a pharmacogenetic passport for inflammatory bowel disease.
    Bangma A; Voskuil MD; Uniken Venema WTC; Brugge H; Hu S; Lanting P; Franke L; Dijkstra G; Festen EAM; Weersma RK
    Aliment Pharmacol Ther; 2020 Jun; 51(11):1105-1115. PubMed ID: 32363635
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacogenomic allele coverage of genome-wide genotyping arrays: a comparative analysis.
    Lenz C; Narang A; Bousman CA
    Pharmacogenet Genomics; 2024 Jun; 34(4):130-134. PubMed ID: 38359167
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Individualizing pharmacogenomic test results in the context of the microbiome.
    Haga SB
    Per Med; 2020 Nov; 17(6):459-468. PubMed ID: 33026284
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Global Frequencies of Clinically Important HLA Alleles and Their Implications For the Cost-Effectiveness of Preemptive Pharmacogenetic Testing.
    Zhou Y; Krebs K; Milani L; Lauschke VM
    Clin Pharmacol Ther; 2021 Jan; 109(1):160-174. PubMed ID: 32535895
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterizing the pharmacogenome using molecular inversion probes for targeted next-generation sequencing.
    Suzuki O; Dong OM; Howard RM; Wiltshire T
    Pharmacogenomics; 2019 Sep; 20(14):1005-1020. PubMed ID: 31559919
    [No Abstract]   [Full Text] [Related]  

  • 40. Preliminary outcomes of preemptive warfarin pharmacogenetic testing at a large rural healthcare center.
    Leary E; Brilliant M; Peissig P; Griesbach S
    Am J Health Syst Pharm; 2019 Feb; 76(6):387-397. PubMed ID: 31415684
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.